Optimizing the sensitivity of detection of respiratory syncytial virus infections in longitudinal studies using the combination of weekly sample testing and biannual serology.
Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Shannon C ConreyDepartment of Quantitative and Population Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, United States.ORCID 0000-0003-3715-5842
Daniel C PayneDivision of Infectious Disease, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID 0000-0002-5871-911X
Maria Deza LeonDepartment of Infectious Disease, Children's Mercy Kansas City, Kansas City, MO, United States.ORCID 0000-0003-0245-2177
Monica EppersonNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0003-1125-5247
Melissa M CoughlinNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0003-1843-6251
Allison R BurrellDivision of Infectious Disease, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID 0000-0002-2271-8430
Claire P MattisonNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-8558-8779
Rachel M BurkeGlobal Development Division, The Gates Foundation, Seattle, WA, United States.ORCID 0000-0002-5678-5826
Julia M BakerNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-7872-316X
Natalie J ThornburgNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0003-3523-3616
Meredith L McMorrowNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-6363-4033
Mary Allen StaatDivision of Infectious Disease, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID 0000-0003-1788-8037
Ardythe L MorrowDepartment of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH, United States.ORCID 0000-0002-1126-4525
Funding
LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI MEINZEN-DERR, JAREEN, STRAWN, JEFFREY ROBERT · 2015 to 2024
$37.5M
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza ImmunityU01AI144673 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI STAAT, MARY A · 2019 to 2025
$36.4M
Molecular Epidemiology in Children's Environmental Health Training Program (MECEH)T32ES010957 · NIEHS · UNIVERSITY OF CINCINNATI · PI Kelly J Brunst · 2001 to 2026
$11.1M
Center for Clinical and Translational Science and TrainingUM1TR005265 · NCATS · UNIVERSITY OF CINCINNATI · PI Jareen Meinzen-Derr, Jeffrey Robert Strawn · 2025 to 2026
$10.6M
MOM2CHild Study: Leveraging systems biology toward discoveries in Maternal Obesity, Milk, and Translation To Child HealthR01HD109915 · NICHD · UNIVERSITY OF CINCINNATI · PI ARDYTHE L MORROW · 2022 to 2026
$3.9M
IMPRINT Cohort U01A1144673Molecular Epidemiology in Children's Environmental Health Training program 5 T32 ES 10957-18MOM2CHild study R01HD109915National Center for Advancing Translational Sciences of the National Institutes of Health UL1TR001425NCATS NIH HHS UL1 TR001425NCATS NIH HHS UM1 TR005265NIAID NIH HHS U01 AI144673NICHD NIH HHS R01 HD109915NIEHS NIH HHS T32 ES010957US Centers for Disease Control and Prevention IP16-004
6 · The paper itself
Abstract
Cohort studies are often challenged by incomplete adherence to sampling regimens, limiting the full capture of disease burden. We describe the detection of respiratory syncytial virus (RSV) infections achieved in a birth cohort using a combination of weekly nasal sample testing and serology. The Pediatric Respiratory and Enteric Viral Acquisition and Immunogenesis Longitudinal Cohort followed 245 maternal-child dyads from birth to age 18 to 24 months. Weekly mid-turbinate nasal swabs were tested for RSV using real-time polymerase chain reaction (RT-qPCR). Serum was tested for RSV pre-fusion F IgG and IgA antibody at age 6 weeks and biannually from 6 to 24 months. Mixed effects classification and regression trees identified antibody thresholds consistent with a RT-qPCR-identified RSV infection using a subset of participants having ≥90% weekly sample adherence (n = 53, 21%). Resulting thresholds were applied to participants with either ≥70% of weekly samples or serum at age 18 to 24 months (n = 194, 79%). Incidence rates were compared using Fisher's exact test. Classification and regression trees identified a log10 change in IgG > 0.32 or IgA > 0.20 as indicative of an RSV infection. Comparing RT-qPCR-only to a combination of RT-qPCR and serology, RSV cumulative incidence (49% vs 75%, P < .001) and incidence rate (0.33 vs 0.71 infections/child-year, P < .001) increased; these rates did not differ from those calculated in those with ≥90% sample adherence.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Optimizing the sensitivity of detection of respiratory syncytial virus infections in longitudinal studies using the combination of weekly sample testing and biannual serology. · full record | OpenQuestion